◆英語タイトル：Seres Therapeutics Inc (MCRB) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’s lead development candidate, SER-109 is an oral microbiome therapeutic and bacterial spore ecology that is being developed for the prevention of recurrent clostridium difficile infection in adults. Seres’ SER-287 is an oral therapy for the treatment of ulcerative colitis, an inflammatory bowel disease. The company utilizes its microbiome therapeutics platform to identify key alterations in the microbiome that are associated with or lead to specific diseases. Seres is headquartered in Cambridge, Massachusetts, the US
Seres Therapeutics Inc Key Recent Developments
Mar 12,2021: Seres Therapeutics to Present at the 31st Annual Oppenheimer Healthcare Conference
Mar 02,2021: Seres Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Updates
Feb 26,2021: Seres Therapeutics to Participate in Upcoming Virtual Investor Conferences
Feb 24,2021: Seres Therapeutics to Host Fourth Quarter 2020 Financial Results and Operational Progress Conference Call on March 2, 2021
This comprehensive SWOT profile of Seres Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Seres Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Seres Therapeutics Inc – Key Information
Seres Therapeutics Inc – Overview
Seres Therapeutics Inc – Key Employees
Seres Therapeutics Inc – Key Employee Biographies
Seres Therapeutics Inc – Key Operational Heads
Seres Therapeutics Inc – Major Products and Services
Seres Therapeutics Inc – History
Seres Therapeutics Inc – Company Statement
Seres Therapeutics Inc – Locations And Subsidiaries
Seres Therapeutics Inc
Other Locations & Subsidiaries
Section 2 – Company Analysis
Seres Therapeutics Inc – Business Description
Seres Therapeutics Inc – Corporate Strategy
Seres Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Seres Therapeutics Inc – Strengths
Seres Therapeutics Inc – Weaknesses
Seres Therapeutics Inc – Opportunities
Seres Therapeutics Inc – Threats
Seres Therapeutics Inc – Key Competitors
Section 3 – Company Financial Performance Charts
Seres Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Seres Therapeutics Inc, Key Information
Seres Therapeutics Inc, Key Ratios
Seres Therapeutics Inc, Share Data
Seres Therapeutics Inc, Major Products and Services
Seres Therapeutics Inc, History
Seres Therapeutics Inc, Key Employees
Seres Therapeutics Inc, Key Employee Biographies
Seres Therapeutics Inc, Key Operational Heads
Seres Therapeutics Inc, Other Locations
Seres Therapeutics Inc, Subsidiaries
Seres Therapeutics Inc, Key Competitors
Seres Therapeutics Inc, SWOT Analysis
Seres Therapeutics Inc, Ratios based on current share price
Seres Therapeutics Inc, Annual Ratios
Seres Therapeutics Inc, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[Seres Therapeutics Inc (MCRB)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら